Sunitinib is a small-molecule, multi-targeted receptor tyrosine kinase inhibitor used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). The gene discussed is NTRK1; the disease is renal cell carcinoma.